# Made Scientific

> Made Scientific is a Princeton, New Jersey-based contract development and manufacturing organization (CDMO) focused exclusively on cell therapies. Formerly BioCentriq, it was rebranded in March 2025 and is backed by South Korea's GC Corporation. The company runs a 60,000 sq. ft. GMP facility with five ISO 7 / Grade B cleanrooms, offering process and analytical development, GMP manufacturing of autologous and allogeneic products, aseptic fill and finish, QC release testing, regulatory consulting, and workforce training, taking cell therapy programs from preclinical development through commercial supply.

- **Founded:** 2019
- **Headquarters:** Princeton, New Jersey, United States
- **Founders:** Syed T. Husain (Chairman and CEO)
- **Team size:** ~150 employees
- **Products:** Process & Analytical Development, GMP Cell Banking & Drug Product Manufacture, GMP Aseptic Fill & Finish, QC Lot Release & Stability, Regulatory Consulting
- **Notable:** Rebranded from BioCentriq to Made Scientific in March 2025 with an expanded commercial mission., Completed a $12 million investment in facility upgrades, equipment and business-system digitization at its Princeton HQ., Operates a 60,000 sq. ft. GMP facility with five ISO 7 / Grade B cleanrooms.

## Products & services

- **Process & Analytical Development** — Development of manufacturing processes and validated analytical methods to prepare cell therapy programs for GMP production and regulatory filings.
- **GMP Cell Banking & Drug Product Manufacture** — GMP manufacturing of autologous and allogeneic cell therapy products, including integrated drug substance and drug product operations.
- **GMP Aseptic Fill & Finish** — Automated aseptic filling and finishing of cell therapy drug products in a controlled, Annex 1-oriented environment.
- **QC Lot Release & Stability** — In-house quality control testing, potency and identity assays, and stability studies supporting batch release.
- **Regulatory Consulting** — Regulatory pathway planning, submissions support, and compliance for US FDA and EU markets.
- **Made Foundry Workforce Training** — Workforce development and training programs building cell therapy manufacturing talent.
- **Equipment & Technology Platforms** — Automated bioprocessing, closed-system processing and manufacturing platforms across seven modalities (T cells, NK cells, HSCs, MSCs, iPSCs, TILs, exosomes).

## Achievements

- Rebranded from BioCentriq to Made Scientific in March 2025 with an expanded commercial mission.
- Completed a $12 million investment in facility upgrades, equipment and business-system digitization at its Princeton HQ.
- Operates a 60,000 sq. ft. GMP facility with five ISO 7 / Grade B cleanrooms.
- Announced a 12,000 sq. ft. expansion adding up to 2,000 manufacturing batches per year at FDA and EU Annex 1 compliance.
- Backed by global pharmaceutical group GC Corporation.
- Strengthened its board in 2026 with senior CDMO and bio-healthcare strategy leaders.

## Latest updates

- **2026-04** — Strengthened board of directors with Ted Dolan (former COO of BioVectra) and Soyoung Park (GC Corporation) to support scale-up and commercial readiness.
- **2025-06** — Announced 12,000 sq. ft. Princeton facility expansion for late-phase and commercial cell therapy manufacturing, FDA and EU Annex 1 compliant.
- **2025-03** — Rebranded from BioCentriq to Made Scientific, backed by a $12M facility investment; GMP services available Q2 2025.

## Links

- Website: https://madescientific.com
- LinkedIn: https://www.linkedin.com/company/madescientific

---

Profile page: https://yespress.io/made-scientific
Published by YesPress — https://yespress.io
Last updated: 2026-07-19